Patent Application
Provisional
App. No. 62/701,814
· Confirmation No. 4181
USE OF RILUZOLE PRODRUGS TO TREAT ALZHEIMER'S DISEASE
Applicant:
Biohaven Pharmaceutical Holding Company Ltd.
Provisional Application Expired
|
⬇ PDF
|
Code | Description | Pages | ||
|---|---|---|---|---|---|
| 2025-04-27 | OATH |
Oath or Declaration filed | 21 | View | |
| 2018-08-14 | APP.FILE.REC |
Filing Receipt | 3 | View | |
| 2018-07-22 | ADS |
Application Data Sheet | 8 | View | |
| 2018-07-22 | SPEC |
Specification | 27 | View | |
| 2018-07-22 | CLM |
Claims | 3 | View | |
| 2018-07-22 | ABST |
Abstract | 1 | View | |
| 2018-07-22 | WFEE |
Fee Worksheet (SB06) | 2 | View | |
| 2018-07-22 | N417 |
Electronic Filing System Acknowledgment Receipt | 3 | View |
Inventors
Attorneys & Agents of Record
Prosecution
- Customer No.
- 129483
- Docket No.
- 20063-PROV
- Confirmation No.
- 4181
Child
Claims priority from a provisional application
→
App. 17/151,577
· US 12,201,618
Filed 2021-01-18
· Patented Case
Child
PCT
Claims priority from a provisional application
→
PCT/US2019/042718
Filed 2019-07-20
· PCT - International Search Report Mailed to IB
Child
Claims priority from a provisional application
→
App. 17/261,057
· US 12,161,633
Filed 2021-01-18
· Patented Case
No recorded assignments were found for this patent.
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this application's details
Quick Facts
- App. No.
- 62/701,814
- Filed
- 2018-07-22
External Links